News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Gerard Walls: Presentation by Dr Gareth Price on clinical impact of real-world studies
Gerard Walls/X
May 6, 2025, 01:50

Gerard Walls: Presentation by Dr Gareth Price on clinical impact of real-world studies

Gerard Walls, Clinical Senior Lecturer and Honorary Consultant in Clinical Oncology at Queen’s University Belfast, posted on X:

“Compelling presentation on how recent design frameworks and quality initiatives mean real-world studies are increasingly a valid method for improving/changing clinical practice by Dr Gareth Price.”

cancer Gareth Price Gerard Walls OncoDaily Oncology
Special Coverage
Opinion
Jun 1, 2025, 13:42
Efficacy of IL-6R Blockade with Sarilumab in a Quadruple Immuno-Oncology Regimen for Patients with Unresectable Stage III/IV Melanoma
Oncolibrary
Jun 1, 2025, 13:02
CheckMate 214 Trial Final 9-Year Results at ASCO 2025: Nivolumab Plus Ipilimumab Continues to Show Long-Term Survival Benefit in Advanced Renal Cell Carcinoma
Oncolibrary
Jun 1, 2025, 12:40
Metacure Cohorts B2 Results: Intensified Hormonal Blockade and SBRT for PSMA-PET Detected Oligometastatic Prostate Adenocarcinoma
Oncolibrary
Jun 1, 2025, 12:03
EV-302 Updates at ASCO 2025: Enfortumab Vedotin Plus Pembrolizumab Doubles Complete Response Rate in Advanced Urothelial Carcinoma
Oncolibrary
Jun 1, 2025, 11:55
Tagitanlimab Boosts Chemotherapy in Nasopharyngeal Cancer: Phase 3 Results at ASCO 2025
Oncolibrary
Jun 1, 2025, 11:51
FIRE-4 Study Results: Cetuximab Re-challenge in Metastatic RAS Wild-Type Colorectal Cancer
Oncolibrary
Jun 1, 2025, 11:45
Combining Darolutamide and Goserelin: A New Frontier in Fighting Salivary Gland Cancer at ASCO 2025
Oncolibrary
Jun 1, 2025, 11:44
SURE-02 Phase 2 Trial Interim Results: Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab Shows Promising Bladder Preservation in Muscle-Invasive Bladder Cancer
Blog
Jun 1, 2025, 11:42
Estela Rodriguez: Day 2 ASCO25 Agenda
Blog
Jun 1, 2025, 11:35
Mario Balsa: Breaking from ASCO 2025 - DESTINY-Gastric04 Trial
Blog
Jun 1, 2025, 11:33
Cristiane Bergerot: Genomic Insights from IMmotion010
Oncolibrary
Jun 1, 2025, 11:24
CheckMate 901 Trial Final Results at ASCO 2025: Nivolumab + Ipilimumab Shows Durable Responses in Cisplatin-Ineligible Metastatic Urothelial Carcinoma